Education
About Us
Working with TipRanks
Follow Us
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
KREBSBIO Stock Chart & Stats
₹69.28
-₹2.80(-2.89%)
At close: 4:00 PM EST
₹69.28
-₹2.80(-2.89%)
Day’s Range― - ―
52-Week Range₹63.55 - ₹129.00
Previous CloseN/A
Volume3.29K
Average Volume (3M)1.01K
Market Cap
₹1.53B
Enterprise Value₹3.78B
Total Cash (Recent Filing)₹1.42M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)―
Beta1.44
Next Earnings
Feb 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.85
Shares Outstanding21,560,587
10 Day Avg. Volume503
30 Day Avg. Volume1,006
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)-1.00
Price to Sales (P/S)3.37
P/FCF Ratio-12.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
KREBSBIO FAQ
What was Krebs Biochemicals & Industries Ltd.’s price range in the past 12 months?
Krebs Biochemicals & Industries Ltd. lowest stock price was ₹63.55 and its highest was ₹129.00 in the past 12 months.
What is Krebs Biochemicals & Industries Ltd.’s market cap?
Krebs Biochemicals & Industries Ltd.’s market cap is ₹1.53B.
When is Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date?
Krebs Biochemicals & Industries Ltd.’s upcoming earnings report date is Feb 02, 2026 which is in 85 days.
How were Krebs Biochemicals & Industries Ltd.’s earnings last quarter?
Krebs Biochemicals & Industries Ltd. released its earnings results on Nov 04, 2025. The company reported -₹2.849 earnings per share for the quarter, missing the consensus estimate of N/A by -₹2.849.
Is Krebs Biochemicals & Industries Ltd. overvalued?
According to Wall Street analysts Krebs Biochemicals & Industries Ltd.’s price is currently Overvalued.
Does Krebs Biochemicals & Industries Ltd. pay dividends?
Krebs Biochemicals & Industries Ltd. does not currently pay dividends.
What is Krebs Biochemicals & Industries Ltd.’s EPS estimate?
Krebs Biochemicals & Industries Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krebs Biochemicals & Industries Ltd. have?
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding.
What happened to Krebs Biochemicals & Industries Ltd.’s price movement after its last earnings report?
Krebs Biochemicals & Industries Ltd. reported an EPS of -₹2.849 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.298%.
Which hedge fund is a major shareholder of Krebs Biochemicals & Industries Ltd.?
Currently, no hedge funds are holding shares in IN:KREBSBIO
Company Description
Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries Ltd. (KREBSBIO) is a leading player in the biotechnology and chemical manufacturing sectors, specializing in the production of biochemicals, enzymes, and specialty chemicals. The company focuses on sustainable and innovative solutions that cater to various industries, including pharmaceuticals, agriculture, and food processing. KREBSBIO's core products include bio-based chemicals, enzyme preparations, and custom biochemical solutions, which are designed to meet the specific needs of its diverse clientele.
Technical Analysis
Aarey Drugs & Pharmaceuticals Ltd.
―
Alpa Laboratories Limited
―
Bafna Pharmaceuticals Limited
―
Bal Pharma Limited
―
Vaishali Pharma Ltd.
―